Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X F Steven Zheng

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Aging|June 29, 2017
Identification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseasesXiao-Ran Long, Yao-Jun Zhang, Mei-Yin Zhang, et al.
Cell Reports|April 14, 2015
Identification of a Non-Gatekeeper Hot Spot for Drug-Resistant Mutations in mTOR KinaseTzung-Ju Wu, Xiaowen Wang, Yanjie Zhang, et al.
Journal of Advanced Research|November 19, 2022
Maf1 is an intrinsic suppressor against spontaneous neural repair and functional recovery after ischemic strokeChi Kwan Tsang, Qiongjie Mi, Guangpu Su, et al.
Oncology Reports|August 15, 2018
MicroRNA‑342‑3p suppresses proliferation and invasion of nasopharyngeal carcinoma cells by directly targeting Cdc42Lu Shi, Ruowen Xiao, Menghe Wang, et al.
Oncotarget|August 27, 2015
Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1ABi-Hong Xu, Xiao-Xing Li, Yang Yang, et al.
Cancer Cell|December 3, 2014
Rab1A is an mTORC1 activator and a colorectal oncogeneJanice D Thomas, Yan-Jie Zhang, Yue-Hua Wei, et al.
Aging|May 26, 2016
Reduced SOD2 expression is associated with mortality of hepatocellular carcinoma patients in a mutant p53-dependent mannerRen Wang, Chen Yin, Xiao-Xing Li, et al.
Molecular Cancer Therapeutics|September 19, 2018
Sorafenib and Carfilzomib Synergistically Inhibit the Proliferation, Survival, and Metastasis of Hepatocellular CarcinomaChao Jiang, Rui Xu, Xiao-Xing Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 25, 2025
Cognitive dysfunction in chemobrain: Molecular mechanisms and therapeutic implicationsHyung-Goo Kim, Mohammad Abdur Rashid, Michael Poleschuk, et al.
Hepatology (Baltimore, Md.)|February 25, 2016
MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcriptionYue Li, Chi Kwan Tsang, Suihai Wang, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Aging|June 29, 2017
Identification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseasesXiao-Ran Long, Yao-Jun Zhang, Mei-Yin Zhang, et al.
Cell Reports|April 14, 2015
Identification of a Non-Gatekeeper Hot Spot for Drug-Resistant Mutations in mTOR KinaseTzung-Ju Wu, Xiaowen Wang, Yanjie Zhang, et al.
Journal of Advanced Research|November 19, 2022
Maf1 is an intrinsic suppressor against spontaneous neural repair and functional recovery after ischemic strokeChi Kwan Tsang, Qiongjie Mi, Guangpu Su, et al.
Oncology Reports|August 15, 2018
MicroRNA‑342‑3p suppresses proliferation and invasion of nasopharyngeal carcinoma cells by directly targeting Cdc42Lu Shi, Ruowen Xiao, Menghe Wang, et al.
Oncotarget|August 27, 2015
Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1ABi-Hong Xu, Xiao-Xing Li, Yang Yang, et al.
Cancer Cell|December 3, 2014
Rab1A is an mTORC1 activator and a colorectal oncogeneJanice D Thomas, Yan-Jie Zhang, Yue-Hua Wei, et al.
Aging|May 26, 2016
Reduced SOD2 expression is associated with mortality of hepatocellular carcinoma patients in a mutant p53-dependent mannerRen Wang, Chen Yin, Xiao-Xing Li, et al.
Molecular Cancer Therapeutics|September 19, 2018
Sorafenib and Carfilzomib Synergistically Inhibit the Proliferation, Survival, and Metastasis of Hepatocellular CarcinomaChao Jiang, Rui Xu, Xiao-Xing Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 25, 2025
Cognitive dysfunction in chemobrain: Molecular mechanisms and therapeutic implicationsHyung-Goo Kim, Mohammad Abdur Rashid, Michael Poleschuk, et al.
Hepatology (Baltimore, Md.)|February 25, 2016
MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcriptionYue Li, Chi Kwan Tsang, Suihai Wang, et al.
Pageof 7